| Product NDC: | 53329-301 |
| Proprietary Name: | Chlorhexidine Gluconate |
| Non Proprietary Name: | Chlorhexidine Gluconate |
| Active Ingredient(s): | .12 mg/mL & nbsp; Chlorhexidine Gluconate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | RINSE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 53329-301 |
| Labeler Name: | Medline Industries, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077789 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100805 |
| Package NDC: | 53329-301-61 |
| Package Description: | 80 BOTTLE in 1 CASE (53329-301-61) > 15 mL in 1 BOTTLE (53329-301-24) |
| NDC Code | 53329-301-61 |
| Proprietary Name | Chlorhexidine Gluconate |
| Package Description | 80 BOTTLE in 1 CASE (53329-301-61) > 15 mL in 1 BOTTLE (53329-301-24) |
| Product NDC | 53329-301 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Chlorhexidine Gluconate |
| Dosage Form Name | RINSE |
| Route Name | ORAL |
| Start Marketing Date | 20100805 |
| Marketing Category Name | ANDA |
| Labeler Name | Medline Industries, Inc. |
| Substance Name | CHLORHEXIDINE GLUCONATE |
| Strength Number | .12 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Cell Wall Integrity [PE] |